Bladder Management For Urinary Retention

Bladder Management For Urinary Retention

For patients with non-obstructive urinary retention, sacral neuromodulation (SNM) provides a treatment option when conventional management has not achieved sufficient improvement.
Send Inquiry
Description
Technical Parameters

Treatment Options for Urinary Retention

For patients with non-obstructive urinary retention, sacral neuromodulation (SNM) provides a treatment option when conventional management has not achieved sufficient improvement. Our bladder management service information covers patient evaluation, treatment suitability, staged SNM procedures, and follow-up support.

Treatment selection depends on the underlying cause of urinary retention, previous treatment outcomes, diagnostic findings, and the patient's clinical condition.

When Sacral Neuromodulation May Be Considered

Sacral neuromodulation may be considered for patients with:

  • Non-obstructive urinary retention.
  • Neurogenic bladder associated with impaired bladder emptying.
  • Persistent urinary retention that has not responded adequately to previous management.

Mechanical urinary obstruction must be evaluated and distinguished from non-obstructive urinary retention before considering SNM. Final treatment suitability requires individual clinical assessment.

Patient Evaluation and SNM Treatment Selection

Before treatment, the patient's medical history, diagnostic records, and previous management results are reviewed.

The evaluation may include:

  • Medical history and previous treatment records.
  • Imaging examination results.
  • Urodynamic test results.
  • Post-void residual urine measurements.
  • Assessment of bladder emptying symptoms and functional changes.

These findings help determine whether SNM testing is an appropriate next step or whether another management approach should be considered.

Two-Stage Sacral Neuromodulation Treatment Process

SNM treatment follows a two-stage process. The initial stimulation test evaluates the patient's response before permanent device implantation.

Stage 1: Temporary Stimulation Testing

A temporary electrode is positioned near the sacral nerve and connected to an external stimulation device. The procedure is generally performed under local anesthesia with imaging guidance.

The testing period is approximately two weeks. Urinary symptom changes are monitored during this period.

Stage 2: Permanent Device Implantation

Patients who achieve at least 50% symptom improvement during the testing stage may proceed to permanent implantation, subject to the treating physician's assessment.

This staged approach provides an opportunity to evaluate the treatment response before permanent implantation.

Available SNM Device Options

Three device configurations are described in the treatment information. Their battery types, estimated service lives, weights, and charging requirements differ.

Specification G132 G131 G134R
Battery type Non-rechargeable Non-rechargeable Rechargeable
Estimated battery life 6–8 years 8–11 years Over 20 years
Weight 25 g 35 g 36 g
Battery capacity 1850 mAh 2500 mAh Not specified
Stimulation voltage 0–10 V 0–10 V 0–10 V
Stimulation current 0–25 mA 0–25 mA 0–25 mA
Charging requirement No routine charging No routine charging Wireless charging
Charging frequency Not applicable Not applicable Approximately every 2–3 months
MRI compatibility stated 1.5T and 3.0T 1.5T and 3.0T 1.5T and 3.0T

G132 and G131 use non-rechargeable batteries and do not require routine charging. G134R uses a rechargeable battery and requires wireless charging approximately every 2–3 months.

The three configurations offer different battery maintenance arrangements. Final device selection depends on clinical requirements and the applicable device instructions. MRI compatibility must be confirmed against the current manufacturer documentation and the specific device conditions.

International Patient Support and Follow-Up

International patients can access support for preliminary assessment, treatment coordination, and follow-up related to urinary retention management.

Available support includes:

  • Remote Medical Record Review: Submission of existing medical records and diagnostic reports for preliminary assessment.
  • Written Treatment Assessment: A stated response target of 1–3 working days after medical records are received.
  • Treatment Coordination: Assistance with discussing further evaluation and potential treatment arrangements.
  • Remote Device Programming: Remote adjustment of SNM device parameters where clinically and technically available.
  • Post-Treatment Follow-Up: Ongoing communication and follow-up support after treatment.

Remote assessment helps patients understand potential treatment options before arranging an in-person evaluation. It does not replace a complete clinical examination or establish treatment eligibility independently.

Request a Medical Assessment for Urinary Retention

If you are considering sacral neuromodulation for urinary retention, you can start with your existing medical information.

Send your medical history, urodynamic test results, imaging reports, or previous treatment records for an initial review. The available information can be used to assess potential treatment options and identify the next steps for clinical evaluation.

Contact us with your existing medical records to discuss bladder management options for urinary retention.

 

Hot Tags: bladder management for urinary retention, China, price, pricelist, quotation, cost, Bladder and Renal Function Impairment, Bladder Contracture, Elevated Post Void Residual, Intravesical Botulinum Toxin Therapy, Post Void Residual Volume, Vesicoureteral Reflux

Send Inquiry
Send Inquiry